Cryoport服务市场 - Cryoport服务的市场主要包括生命科学行业，支持生物制药/制药、动物健康和生殖医学市场[7] - 生物制药/制药市场中，细胞和基因疗法已成为生物药物开发的快速增长领域，2022年筹集了超过120亿美元的资金[8] 公司收购情况 - Cryoport在2019年收购了Cryogene Labs，提供温控生物储存解决方案，目前位于德克萨斯州休斯顿[10] - 2020年10月，Cryoport收购了CRYOPDP，提供高价值、时间紧迫和温度敏感的生物制药/制药行业的创新温控物流解决方案[11] - 2020年10月，Cryoport还收购了MVE Biological Solutions，提供生命科学行业的冷冻生物储存和运输系统[13] - Cryoport在2021年4月和5月分别收购了澳大利亚的Critical Transport Solutions Australia和比利时的F-airGate，以增强CRYOPDP在亚太和欧洲地区的温控物流能力[14] - 2022年4月，Cryoport收购了法国的Cell&Co BioServices，进一步增强了其全球温控供应链能力[15] - 2022年7月，Cryoport收购了西班牙的Polar Expres，提供专门针对生命科学行业的温控物流解决方案[16] - 2022年7月，Cryoport还收购了比利时的Cell Matters，提供冷冻生物学专业知识，为细胞疗法提供一致、高质量的起始材料[17] 产品和服务 - Fusion®低温冷冻器是适合偏远地区、孤立实验室、高海拔设施或没有现有液氮基础设施的完美解决方案[21] - MVE生物解决方案的Vario®低温系统支持-20°C至-150°C的温度范围，与传统机械冷冻器相比，功耗仅为1%且整体运营成本节省70%[22] - Cryoport通过技术驱动的供应链解决方案建立了市场领先地位，提供集成平台，为生命科学行业提供保障[23] 公司发展和战略 - 公司从2020年第四季度开始调整报告结构，形成一个可报告的部门，不再按产品和服务、地理区域或监管环境组织[26] - 公司的研发工作重点是不断探索能够改进服务、产品和解决方案功能的新技术[31] 环境、社会和治理（ESG） - 公司于2020年开始进行ESG政策、程序和绩效的内部审查[40] - 公司根据SASB和TCFD的框架和标准公开披露ESG信息[41] - 公司的ESG策略重点关注温室气体排放[43] - 公司使用世界资源研究所的温室气体协议标准计算公司的温室气体排放[44] 公司治理和道德 - 公司致力于诚实、真实和透明的运营，遵守最高的道德和公司治理标准[61] 财务情况 - 公司将多余现金投资于高投资级货币市场基金和投资级短期至中期固定收益证券[171] - 截至2022年12月31日，可转换优先票据的估计公允价值为3.025亿美元[172] - 公司在美国和其他国家运营，面临外汇风险，主要涉及欧元、英镑、人民币和印度卢比等货币[173]

Cryoport, Inc. (NASDAQ:CYRX) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Todd Fromer - Managing Partner-KCSA Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Conference Call Participants Michael Almisry - SVB Securities Matt Stanton - Jefferies John Sourbeer - UBS David Larsen - BTIG David Saxon - Needham & Company Jacob Johnson - Stephens Yuan Zhi - B. Riley Securities Operator Good afternoo ...

Cryoport, Inc. (NASDAQ:CYRX) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET Company Participants Todd Fromer - Managing Partner-KCSA Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Dr. Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development and Investor Relations Conference Call Participants Puneet Souda - SVB Securities John Sourbeer - UBS Brandon Couillard - Jefferies David Larsen - BTIG David Saxon - Needham & Comp ...

Cryoport, Inc. (NASDAQ:CYRX) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Todd Fromer – Managing Partner-KCSA Jerrell Shelton – Chief Executive Officer Tom Heinzen – Vice President, Corporate Development and Investor Relations Robert Stefanovich – Chief Financial Officer Mark Sawicki – Chief Scientific Officer Conference Call Participants John Sourbeer – UBS Richard Baldry – Roth Capital Yuan Zhi – B. Riley Securities David Saxon – Needham & Co. David Larsen – BTIG Jacob J ...

CRYOPORT, INC. (NASDAQ: CYRX) FIRST QUARTER 2022 IN REVIEW May 5, 2022 Important information This document provides a review of Cryoport, Inc.'s recent financial and operational performance and a general business outlook. It is designed to be read by interested parties before the regularly scheduled quarterly conference call, which, for this quarter, is scheduled for 5:00 p.m. ET on Thursday, May 5, 2022. Therefore, the conference call will be in the format of a questions and answers session and will addres ...

Cryoport, Inc. (NASDAQ:CYRX) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Todd Fromer - President, KCSA Strategic Communications Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - CSO Conference Call Participants John Sourbeer - UBS Brandon Couillard - Jefferies Michael Jones - SVB Securities Joseph Conway - Needham & Co. Paul Knight - KeyBanc David Larsen - BTIG Yuan Zhi - B. Riley Securities Jacob Johnson - Stephens Operator Thank you for standing by. This is the ...

Cryoport, Inc. (NASDAQ:CYRX) Q4 2021 Earnings Conference Call February 24, 2022 5:00 PM ET Â Company Participants Todd Fromer - President, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Dr. Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development and IR Conference Call Participants Michael Jones - SVB John Sourbeer - UBS David Saxon - Needham & Co. Brandon Couillard - Jefferies David Larsen - BTIG Ope ...

Cryoport, Inc. (NASDAQ:CYRX) Q3 2021 Earnings Conference Call November 4, 2021 5:00 PM ET Company Participants Todd Fromer – President, KCSA Strategic Communications Jerrell Shelton – Chief Executive Officer Mark Sawicki – Chief Scientific Officer Robert Stefanovich – Chief Financial Officer Thomas Heinzen – Vice President of Corporate Development and Investor Relations Conference Call Participants John Sourbeer – UBS Chad Wiatrowski – SVB Leerink Matt Andrews – Jefferies Paul Knight – KeyBanc David Larsen ...

Cryoport, Inc. (NASDAQ:CYRX) Q2 2021 Earnings Conference Call August 5, 2021 5:00 PM ET Executives Todd Fromer - Managing Partner-KCSA Jerrell Shelton - Chairman, President and Chief Executive Officer Robert Stefanovich - Chief Financial Officer, Treasurer and Corporate Secretary Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President-Corporate Development & Investor Relations Analysts Matt Andrews - Jefferies Andrew D'Silva - B. Riley Securities David Larsen - BTIG Jacob Johnson - Stephens ...

Cryoport, Inc. (NASDAQ:CYRX) Q1 2021 Results Conference Call May 4, 2021 5:00 PM ET Company Participants Todd Fromer - Managing Partner, KCSA Jerrell Shelton - CEO Robert Stefanovich - CFO Dr. Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP, Corporate Development and IR Conference Call Participants Matt Andrews - Jefferies Andrew DÂ'Silva - B. Riley Paul Knight - KeyBanc David Saxon - Needham John Sourbeer - UBS Richard Baldry - ROTH Capital Partners Operator Thank you for standing by. This is t ...